NCT04809467 · Interventional trial
A Study Evaluating Safety, PK, and Efficacy of Tafasitamab and Parsaclisib in Participants With Relapsed/Refractory Non Hodgkin Lymphoma (R/R NHL) or Chronic Lymphocytic Leukemia (CLL)
Overall registry status Terminated
Phase 1 · Phase 2
Conditions Chronic Lymphocytic Leukemia, Non Hodgkin Lymphoma
Delaware Valley sites
- Jefferson University Hospitals · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory